Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36310ab39fe797510fbf5c0408149b4f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20 |
filingDate |
2010-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8e39d217630ca5f729a7ab900951152 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e27b963454b4c319426f2f57237ff53a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26342a4acb0902f32f799b0bea174c6c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46f5d1c47a5efa38ea8ee122f18d215a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1445db9ca693d4f801ee29396f0d68ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a48126798911423d95900d4b5578c0e3 |
publicationDate |
2011-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
MX-2011008922-A |
titleOfInvention |
RILUZOL WATERPROOF SUSPENSIONS. |
abstract |
The present invention relates to physically and chemically stable aqueous suspensions of riluzole, together with the manufacturing methods thereof. Such aqueous suspensions comprise riluzole in the form of particles and at least one wetting agent, preferably a surfactant. Riluzole is in amounts from about 0.1% to about 20% in w / v and has an average particle size of less than 200 mum; such suspensions are devoid of known local anesthetic effects (mouth) of riluzole. |
priorityDate |
2009-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |